PR Newswire BiotechOriginal article
JaxBio Announces npj Precision Oncology Study Showing $60 cfDNA Methylation Chip Detected Lung Cancer Signals in Blood Without Sequencing
Data Readoutpositive$60 cfDNA Methylation ChipPositive
AI Analysis
Summary
JaxBio Technologies announced peer-reviewed results in npj Precision Oncology demonstrating a $60 cfDNA methylation chip that detected lung cancer signals in blood without requiring sequencing using hybrid capture on-chip and enzyme-based fluorescent labeling methods.
Outcome Details
Peer-reviewed study published in npj Precision Oncology showing cfDNA methylation chip detected lung cancer signals in blood without sequencing
Importance:5/10
Sentiment:
0.60
liquid biopsycfDNA methylationlung cancer detectionpeer-reviewed studyprecision oncologydiagnostic
Read the original article
Published by PR Newswire Biotech on July 2, 2026 12:55 PM